University City Science Center Launches Proof-of-Concept Funding Program
The QED Program (from the Latin “Quod Erat Demonstrandum” – “that which is demonstrated”) is a comprehensive proof-of-concept research opportunity for commercialization of early-stage life science technologies being developed at academic research organizations in the Greater Philadelphia Region. It will integrate four elements that are critical to successfully and efficiently performing early-stage proof-of-concept technology assessments: grant funding, business advice, market drivers and guidance to exit.
- Companies:
- Children's Hospital of Philadelphia
- Drexel University
- Lankenau Institute of Medical Research
- Rutgers University
- Select Greater Philadelphia
- Temple University
- Temple University Press
- The Wistar Institute
- Thomas Jefferson University
- University City Science Center
- University of Delaware
- University of Pennsylvania
- University of the Sciences in Philadelphia
- People:
- Stephen S. Tang
- Tom Morr
Related Content
Comments
